CANCER TREATMENT

Dec 13 2024HEALTH

Battle with Insurance: A Cancer Patient's Struggle

Imagine being in the middle of chemotherapy and having to fight your insurance company to get the medicine you need. That's what happened to Arete Tsoukalas, a 26-year-old law student from Indiana. After being diagnosed with leukemia, she found out her insurance required a $13, 000 monthly copay for

reading time less than a minute
Dec 12 2024SCIENCE

Copper Nanozymes Starve Tumors and Trigger Cell Death

Lung cancer treatment faces two big hurdles: upsetting the tumor's environment and making sure it stays that way. Scientists tackled this by creating a special nanozyme called Cu2O@Au. It's like a tiny catalyst, breaking down glucose at the tumor site. This starves the tumor of energy and creates hy

reading time less than a minute
Nov 30 2024HEALTH

Tiny Particles Fight Cancer Smarter

Cancer cells are unique. They're packed with acid and glutathione, and they crave oxygen. Scientists created tiny particles, known as AMON, to help combat cancer. These particles hold a drug called doxorubicin and a nitric oxide donor, wrapped together like a special package. To guide them to cancer

reading time less than a minute
Nov 29 2024HEALTH

Understanding Biliary Tract Cancer Treatments and Survival Rates

Biliary tract cancer (BTC) is a rare and often deadly disease that's usually found at an advanced stage. The standard first-line treatment is a combination of gemcitabine and cisplatin. However, there's no clear global standard for second-line treatments after chemotherapy. New therapies targeting s

reading time less than a minute
Nov 27 2024HEALTH

Palbociclib and Letrozole: New Hope for Breast Cancer Patients with Residual Disease

In the fight against breast cancer, doctors are constantly searching for better ways to treat the disease. One recent study, known as the PROMETEO II trial, looked into combining two drugs - palbociclib and letrozole - to help patients with a specific type of breast cancer. This type of cancer is ho

reading time less than a minute
Nov 27 2024HEALTH

Unraveling the Potential of Spirooxindole Drugs in Cancer

Cancer remains a major health threat globally, making the search for new treatments crucial. Scientists are now exploring spirooxindole drugs as a promising avenue. These drugs have a distinctive structure that allows them to target various factors involved in cancer growth, such as kinases and rece

reading time less than a minute
Nov 26 2024HEALTH

How a Plant Compound Slows Down Colorectal Cancer

Colorectal cancer is notorious for its stealthy spread, courtesy of a tiny factory inside cancer cells known as the KITENIN/ErbB4 complex. This duo aids in the cancer's journey to different parts of the body, which is frightening because it often leads to fatal complications. But don't lose hope jus

reading time less than a minute
Nov 26 2024HEALTH

UV Light Boosts Cancer-Cell Delivery of Magnetic Nanoparticles

You know how cancer cells can sometimes come back after treatment? Scientists found a way to use UV light to help these tough cells produce tiny delivery containers called microparticles. These microparticles can carry tiny magnetic bits, called superparamagnetic iron oxide nanoparticles (MNPs), rig

reading time less than a minute
Nov 25 2024HEALTH

Ivermectin: An Unexpected Ally in the Fight Against Esophageal Cancer

Esophageal squamous cell carcinoma (ESCC) is a growing concern globally, with limited effective treatments available. There’s a drug called ivermectin that could potentially change the game. Usually used against parasites, ivermectin has shown promise in slowing down cancer growth in lab studies. Sc

reading time less than a minute
Nov 23 2024HEALTH

Cancer Care in Upper Franconia: How Well Are We Doing?

Cancer is a significant health issue in Germany, coming in second as the most common cause of death. To ensure high-quality treatment, experts recommend seeking care in certified cancer centers. In this study, researchers aimed to find out how many people with primary tumors in Upper Franconia could

reading time less than a minute